Type 1 diabetes

Causal associations between type 1 diabetes and COVID-19 infection and prognosis: a two-sample Mendelian randomization study

BMJ Open Diabetes Res CarePublished Two-sample Mendelian randomization study

Authors' conclusion

Type 1 diabetes had a causal effect on severe COVID-19 and death after COVID-19 infection. Further mechanistic studies are needed to explore the relationship between type 1 diabetes and COVID-19 infection and prognosis.

Study context

Population
European population; T1D GWAS summary statistics (discovery: 15,573 cases, 158,408 controls; replication: 5913 cases, 8828 controls)
Comparison
Genetically predicted T1D vs no T1D
Outcome
COVID-19 infection and prognosis
Methodological detailsreverse Mendelian randomization (MR) analysis, discovery and replication samples
  • Reverse MR analysis
  • Discovery and replication samples

Main finding

As reported in the abstract

Severe COVID-19: OR (95% CI 1.034 to 1.114), pFDR=1.15×10-3

1.073

COVID-19 death: OR (95% CI 1.033 to 1.119), pFDR=1.15×10-3

1.075

Further findings

Severe COVID-19 and COVID-19 death (replication sample)

Severe COVID-19: OR (95% CI 1.029 to 1.081), pFDR=1.59×10-4
1.055
COVID-19 death: OR (95% CI 1.026 to 1.081), pFDR=3.50×10-4
1.053

COVID-19 positive, hospitalized COVID-19, time to end of symptoms (colchicine and placebo)

No causal association with T1D

Reverse causality

Reverse MR analysis showed no reverse causality

Original publication

Causal associations between type 1 diabetes and COVID-19 infection and prognosis: a two-sample Mendelian randomization study. BMJ Open Diabetes Res Care. Published 13 June 2023. doi:10.1136/bmjdrc-2022-003167

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.